Kappac Pharma Ltd

Kappac_Pharma06 Jan 2015
Pharmaceuticals
0.00 (0.00%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Kappac Pharma
Kappac Pharma Ltd
Pharmaceuticals
Kappac_Pharma06 Jan 2015
0.00 (0.00%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Kappac Pharma - Share Price & Details

Lowest Today
112.85
Highest Today
112.85
Today’s Open
112.85
Prev. Close
112.85
52 Week High
112.85
52 Week Low
0
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
-82.23%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
10.02
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Price Performance

-22.52 %
1 Wk
-55.88 %
1 M
-69.44 %
3 M
-82.23 %
1 Y
-14.18 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Kappac Pharma Ltd
₹112.85(0.00/0.00%)
112.85+0.00341.48-82.230.0010.02
Astrazeneca Pharma India Ltd
₹6,458.00(+107.05/1.69%)
6,458.00+107.0516,145.0076.98107.9922.68
Cipla Ltd
₹1,565.30(+21.85/1.42%)
1,565.30+21.85126,389.4859.9634.034.52
Bliss GVS Pharma Ltd
₹106.00(+0.65/0.62%)
106.00+0.651,109.7232.9314.641.12
Abbott India Ltd
₹27,452.30(-160.50/-0.58%)
27,452.30-160.5058,336.1424.2048.5615.77
Amrutanjan Health Care Ltd
₹749.85(-7.00/-0.92%)
749.85-7.002,167.8623.9748.197.51

About Kappac Pharma Ltd

Kappac Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 341.48 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -1.99 crores for the quarter ended December 2018. The company management includes , Rakesh Vekariya,Arun Vaghasiya,Ramjibhai Maganbhai Patel,Yunusbhai Satarbhai Syya (Kappac Pharma Ltd) among others.
Chairman
Registered office
303 Mahajben Arched Masjid,13/A Chakala Cross Lane,Mumbai,Maharashtra,400003
FAX :
Background
Incorporation Year1981
Face Value₹10
Market Lot1

Latest News

Will Nifty touch 24,000 this week? Top 5 factors at play
The Nifty index remains within a narrow range of 23,200-23,500, with a potential breakout above 23,600 leading to a rally up to 24,000. Key factors influencing the market this week include ⏩Global markets, ⏩Macro cues, ⏩FII flow, ⏩Govt &⏩Technicals. Meanwhile, FII selling has reduced, & retail investors are eager to buy every dip, but FPIs may turn sellers again if the market rallies further.
16 Jun 2024 | 11:55 AM
Indian room air-conditioner market to reach Rs 50,000 crore by FY29: Voltas
The Indian room air-conditioners (RAC) market is expected to grow at a CAGR of 12% to reach Rs 50,000 crore by FY 2028-29, driven by factors like hot summers and rising disposable incomes. The market leader, Voltas, aims to reinforce its market leadership through expansion of Exclusive Brand Outlets and other channels. The industry, however, faces challenges such as import dependency.
16 Jun 2024 | 04:53 PM
Global Rate-Cut Juggernaut Is Struggling to Start
Central banks in the UK, Australia, Norway, and Switzerland are expected to keep interest rates on hold this week, with policymakers hesitant to cut rates due to lingering price pressures and uncertainty. The Bank of England is likely to wait until August to cut rates, while the Swiss National Bank may avoid a second rate reduction.
16 Jun 2024 | 04:37 PM
Infra stocks to continue their run beating capital goods shares
Domestic infrastructure and capital goods stocks have seen significant growth, with capital goods stocks tripling in value and infra stocks doubling over the past three years. The RBI has raised its GDP growth forecast to 7.2% for FY25, indicating a strong outlook for these sectors. Capital goods stocks have outperformed infra stocks due to lower capital requirements and stronger earnings.
16 Jun 2024 | 04:36 PM
Wipro wins multi-million dollar deal from Standard Chartered
Wipro Ltd has secured a major IT outsourcing contract from Standard Chartered Plc, marking its second significant win under CEO Srinivas Pallia. The financial terms of the deal were not disclosed, but the contract is expected to generate significant revenue for Wipro. This win is seen as a major boost to Wipro's growth prospects and a testament to Pallia's leadership.
16 Jun 2024 | 04:36 PM

How to buy Kappac Pharma shares on nse?

To buy Kappac Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Kappac Pharma share price today?

The Kappac Pharma shares price on nse is Rs.112.85 today.

What is the market cap of Kappac Pharma shares on BSE ?

The company has a market capitalization of Rs.341.48Cr

What is the PE & PB ratio of Kappac Pharma shares ?

PE is 0 and PB is 10.02

What is the 52 Week High and Low of Kappac Pharma shares?

Kappac Pharma stock price high: Rs.112.85 Kappac Pharma stock price low: Rs.0